Intelligent Bio Solutions (INBS) EBT (2019 - 2024)
Intelligent Bio Solutions has reported EBT over the past 6 years, most recently at -$3.0 million for Q1 2024.
- Quarterly results put EBT at -$3.0 million for Q1 2024, up 52.99% from a year ago — trailing twelve months through Mar 2024 was -$10.3 million (up 12.78% YoY), and the annual figure for FY2024 was -$10.3 million, up 18.29%.
- EBT for Q1 2024 was -$3.0 million at Intelligent Bio Solutions, down from -$2.0 million in the prior quarter.
- Over the last five years, EBT for INBS hit a ceiling of -$111107.0 in Q1 2020 and a floor of -$6.4 million in Q1 2023.
- Median EBT over the past 5 years was -$2.0 million (2023), compared with a mean of -$2.1 million.
- Biggest five-year swings in EBT: crashed 2728.5% in 2021 and later skyrocketed 57.23% in 2022.
- Intelligent Bio Solutions' EBT stood at -$2.0 million in 2020, then tumbled by 74.03% to -$3.5 million in 2021, then surged by 38.52% to -$2.1 million in 2022, then increased by 5.13% to -$2.0 million in 2023, then plummeted by 47.79% to -$3.0 million in 2024.
- The last three reported values for EBT were -$3.0 million (Q1 2024), -$2.0 million (Q4 2023), and -$2.6 million (Q3 2023) per Business Quant data.